Skip to main content

Intratympanic injection of dexamethasone for controlling subjective idiopathic tinnitus




Tinnitus is a common and distressing symptom that is characterized by the perceived sensation of sound without a corresponding external stimulus. Intratympanic (IT) dexamethasone injection is used for the treatment of tinnitus by introducing the substance through the tympanic membrane, resulting in reduced systemic toxicity and a higher perilymph steroid level.

Aim of the study

The aim of this study was to evaluate the effect of IT dexamethasone injection for controlling idiopathic tinnitus of cochlear origin.

Materials and methods

A total of 30 patients with subjective idiopathic tinnitus for at least 6 months were subjected to IT injection of dexamethasone, once per week for 4 weeks. Improvement in tinnitus was assessed using pure-tone audiometry, speech audiometry, tinnitus matching test, and Tinnitus Handicap Inventory by comparing the results before and after therapy.


Pure-tone audiometry did not show significant improvement. However, there was a significant improvement in speech audiometry, tinnitus loudness, and Tinnitus Handicap Inventory after the end of the four injections and in the subsequent evaluations 1 and 3 months later.


IT dexamethasone injection could be a simple and effective method for controlling subjective idiopathic tinnitus. The tinnitus may not disappear, but will be alleviated, enabling the patient to cope more easily with the disease, and thus reducing their handicap.


  1. 1

    Nondahl DM, Cruickshanks KJ, Wiley TL, Klein R, Klein BE, Tweed TS. Prevalence and 5-year incidence of tinnitus among older adults: the epidemiology of hearing loss study. J Am Acad Audiol 2002; 13: 323–331.

    Article  Google Scholar 

  2. 2

    Sakata E, Itoh A, Itoh Y. Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996; 2: 129–135.

    CAS  PubMed  Google Scholar 

  3. 3

    Vio MM, Holme RH. Hearing loss and tinnitus: 250 million people and a US$10 billion potential market. Drug Discov Today 2005; 10: 1263–1265.

    Article  Google Scholar 

  4. 4

    Dobie, RA. A review of randomized clinical trials in tinnitus. Laryngoscope 1999; 109:1202–1211.

    CAS  Article  Google Scholar 

  5. 5

    Robinson SK, Viirre ES, Stein MB. Antidepressant Therapy for Tinnitus. In: Snow J Jr., editor. Tinnitus: Theory and Management. BC Decker; Hamilton, Canada: 2004. chapter 20, p. 278–293.

    Google Scholar 

  6. 6

    Jahnke K. The blood-perilymph barrier. Arch Otorhinolaryngol 1980; 228: 29–34.

    CAS  Article  Google Scholar 

  7. 7

    Barany R. The control of tinnitus by injecting intravenous local anesthetics. Acta Otlaryngol 1935; 23: 201–203.

    Article  Google Scholar 

  8. 8

    Schuknecht HF. Ablation therapy for the relief of Meniere’s disease. Laryngoscope 1956; 66: 859–870.

    CAS  Article  Google Scholar 

  9. 9

    Shulman A, Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 2000; 6: 10–20.

    CAS  PubMed  Google Scholar 

  10. 10

    Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D. Intratympanic dexamethasone treatment for control of subjective idiophatic tinnitus: our clinical experience. Int Tinnitus J 2002; 8: 11–113.

    Google Scholar 

  11. 11

    Araújo MF, Oliveira CA, Bahmad FM Jr. Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 2005; 131: 113–117.

    Article  Google Scholar 

  12. 12

    Parelkar K, Thorawade V, Jagade M, Nagle S, Nataraj R, Pandare M, et al. Intratympanic injections: an unsolved mystery. Int J Otolaryngol Head Neck Surg 2015; 4: 124–132.

    Article  Google Scholar 

  13. 13

    Soliman S, Fathalla A, Shehata W. Development of Arabic suggested spondiac words test. Ain Shams Medical Congress 1985; 2: 1220.

    Google Scholar 

  14. 14

    Soliman S. Speech discrimination audiometery using Arabic phonetically balanced words. Ain Shams Med J 1976; 27: 27–30.

    Google Scholar 

  15. 15

    Sandlin RE, Olsson RT. Subjective tinnitus: it’s mechanism and treatment. In: M Valenete, H Hosford, GR Ross, editors. Audiology treatment. New York: Thieme; 2000. 691–697.

    Google Scholar 

  16. 16

    McCombe A, Baguley D, Coles R, McKenna L, McKinney C, Windle-Taylor P, British Association of Otolaryngologists, Head and Neck Surgeons. Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clin Otolaryngol Allied Sci 2001; 26:388–393.

    CAS  Article  Google Scholar 

  17. 17

    Sakata H, Kojima Y, Koyama S, Furuya N, Sakata E. Treatment of cochlear tinnitus with intratympanic infusion of 40% lidocaine into the tympanic cavity. Int Tinnitus J 2001; 7: 46–50.

    CAS  PubMed  Google Scholar 

  18. 18

    Yilmaz I, Ozluoglu LN, Cagici CA, Akkuzu G, Ozgirgin N, Yavuz H, Yalcintas D. Effectiveness of intratympanic dexamethasone on tinnitus: a clinical experience. Turk Arch Otolaryngol 2006; 44: 81–87.

    Google Scholar 

  19. 19

    Hamid MA. Intratympanic dexamethasone perfusion in Meniere’s disease. Presented at the spring meeting of the American Neurotology Society, Palm Desert, CA, May 2001:12.

  20. 20

    Dennis RT. Ion homeostasis and inner ear disease. In: Hamid M, Sismanis A, editors. Medical otology and neurotoyology. A clinical guide to auditory and vestibular disorders. New York: Thieme; 2006. 21–32.

    Google Scholar 

  21. 21

    Mahmoud EA, Hafize ME. Transtympanic dexamethazone treatment for control of subjective idiopathic tinnitus. El-minia Med Bull 2004; 15: 240–252.

    Google Scholar 

  22. 22

    An YH, Yu KK, Kwak MY, Yoon SW, Shim HJ. Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus. Otol Neurotol 2014; 35: 1330–1337.

    Article  Google Scholar 

  23. 23

    She W, Dai Y, Du X, Chen F, Zhang Q, Jiang P, Cui X. A short term study on the efficacies of intratympanic prednisolone and dexamethasone injection for subjective tinnitus. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008; 22: 871–873. 877

    PubMed  Google Scholar 

  24. 24

    Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109: 1–17.

    CAS  Article  Google Scholar 

  25. 25

    Araújo MFS, Oliveira CA, BahmadJr FM. Intratympanic Dexamethasone Injections as a Treatment for Severe, Disabling Tinnitus. Arch Otolaryngol Head Neck Surg 2005; 131: 113–117.

    Article  Google Scholar 

  26. 26

    House JW. Therapies for tinnitus. Am J Otol 1989; 10: 163–165.

    CAS  PubMed  Google Scholar 

  27. 27

    Itoh A, Sakata E. Trearment of vestibular disorders. Acta Otolaryngo 1991; 481: 617–623.

    CAS  Article  Google Scholar 

  28. 28

    Pondugula SR, Sanneman JD, Wangemann P, Milhaud PG, Marcus DC. Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel. American Journal Physiol Renal Physiol 2004; 286: 1127–1135.

    Article  Google Scholar 

  29. 29

    Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, et al. Dexamethasone Pharmacokinetics in the Inner Ear: Comparison of Route of Administration and Use of Facilitating Agents. Otolaryngology-Head and Neck Surgery 2000; 122: 521–528.

    CAS  PubMed  Google Scholar 

  30. 30

    Topak M, Sahin-Yilmaz A, Ozdoganoglu T, Yilmaz, HB, Ozbay M, Kulekci M. Intratympanic Methylprednisolone Injections for Subjective Tinnitus. Journal of Laryngology & Otology 2009; 123: 1221–1225.

    CAS  Article  Google Scholar 

  31. 31

    Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Trial. J Am Med Assoc 2011; 305: 2071–2079.

    CAS  Article  Google Scholar 

  32. 32

    Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012; 146: S1–S35.

    Article  Google Scholar 

  33. 33

    Belhassen S, Saliba I. Pain assessment of the intratympanic injections: a prospective comparative study. Eur Arch Otorhinolaryngol 2012; 269: 2467–2473.

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Enass Sayed Mohamed MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

Rights and permissions

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Weshahy, H.F., Mohamed, E.S., Salem, M.A.M. et al. Intratympanic injection of dexamethasone for controlling subjective idiopathic tinnitus. Egypt J Otolaryngol 31, 224–230 (2015).

Download citation


  • intratympanic dexamethasone
  • subjective idiopathic tinnitus
  • Tinnitus Handicap Inventory